产品中心 / 产品类型 / ELISA试剂盒 / ELISA 抗体对

Rabbit anti-Human IL-6 mAb (CAP) (RM17601)

This standard curve is only for demonstration purposes. A standard curve should be generated for eachassay.

All(1)|
货号: RM17601
促销价:   ¥2100
抗体定制服务咨询

文献引用 (0)

详细信息

产品名称
Rabbit anti-Human IL-6 mAb (CAP)
货号
RM17601
免疫原
Recombinant IL-6 Protein
纯化方式
Affinity purification
同种型
Rabbit IgG
内毒素水平
< 1.0 EU/μg of the protein by LAL method.
存储溶液
Supplied as a 0.2um filtered solution in PBS with 0.1%Braveds MB-1,PH 7.4.
CrossReactivity
No cross-reactivity in ELISA assay with recombinant
hCntf、hG-CSF、hGM-CSF、hIL-1A、hIL-1B、hIL-2、hIL-3、hIL-4、hIL-6RA、hIL-6RB、hIL-7、hIL-8、hIL-11、hIL-12、hLIF、hOSM、hTNFA、mIL-2、mIL-4、mIL-5、mIL-6、mIL-11、mIL-12
存储条件
This antibody can be stored at 2℃-8℃ for one monthwithout detectable loss of activity. Antibody products are stable for twelve months fromdate of receipt when stored at -20℃ to -80℃. Preservative-Free.Avoid repeated freeze-thaw cycles.

* This package insert must be read in its entirety before using this product.

应用

Human IL-6 Sanwich ELISA Immunoassay

 Recommended
Concentration
Sample
ELISA Capture1-4ug/mLRabbit anti-Human IL-6(CAP)(Cat. No.RM17601)
ELISA Detection0.033-0.13ug/mLRabbit anti-Human IL-6(DET)(Cat. No.RM17602)
Standard1.56-100pg/mLRecombinant Human IL-6 Protein

背景信息

Interleukin 6 (IL-6) is also known as HGF, BSF2,HSF, IFNB2 and IL-6, originally identified as a B cell differentiation factor, is a multifunctional cytokine that regulates immune responses, hematopoiesis, acute phase responses, and inflammatory reactions.It is secreted by T cells, macrophages , monocytes, fibroblasts,endothelial cells,et.al. to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation. Interleukin 6 has been shown to interact with interleukin-6 receptor and glycoprotein. IL-6 is relevant to many disease processes such as diabetes,atherosclerosis, depression,Alzheimer’s Disease,systemic,lupus erythematosus,prostate cancer and rheumatoid arthritis. Advanced/metastatic cancer patients have higher levels of IL-6 in their blood.Hence there is an interest in developing anti-IL-6 agents as therapy against many of these diseases.

>